Electronic Screening Could Lower Risk of Hospital Sepsis Deaths, Study Finds

Electronic Screening Could Lower Risk of Hospital Sepsis Deaths, Study Finds

Hospitals that used electronic screening to detect sepsis in patients reported fewer deaths from the serious infection, than facilities that use more traditional techniques, according to the findings of a new study.

Sepsis is a life-threatening infection that damages the bodyโ€™s immune system and shuts down the organs. It can progress quickly and carries a high risk of death if not promptly detected and treated.

Hospitalization increases the likelihood that patients will come into contact with bacteria that can cause infections such as sepsis, which occurs in roughly one-quarter of patients who are admitted to a hospital.

In findings published in the Journal of the American Medical Association (JAMA) on December 10, researchers from Saudi Arabia conducted a randomized trial of 29,442 patients in 45 wards in five hospitals in Saudi Arabia who underwent electronic monitoring. The team, led by Dr. Yasmeen M. Arabi, compared those patients to 30,613 patients who didnโ€™t have electronic monitoring.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Electronic screening utilizes a system that automatically looks for key indicators of sepsis by the infectionโ€™s effect on the patientโ€™s vital statistics. It monitors for โ€œred flagsโ€ such as low blood pressure, high blood pressure and fever, and then issues an alert to healthcare providers, as well as alerts to ensure the patient receives timely treatments, medications, lab testing and other crucial attention.

Patients in the screening group who were subject to an electronic screening alert had a lower death rate within 90 days of hospitalization than those in the non-electronically screened group, the data indicates. This is regardless of whether the alert was for warning signs of sepsis, or to remind healthcare providers of needed medical procedures, the researchers determined.

Within 12 hours of the alert, patients in the electronic screening group were more likely to have necessary lab tests and other medical attention, like serum lactate tested and IV fluid ordered, compared to the non-screening group. Patients in the electronic screening group were also able to reduce or stop taking drugs that increased blood pressure, for those with dangerously low blood pressure.

Electronic screening patients also had lower rates of antibiotic-resistant bacterial infections that are especially hard to treat, the findings indicate.

However, researchers did note that patients in the screening group underwent more โ€œcode blueโ€ calls, needed more kidney replacement therapy, and had higher rates of clostridium difficile (C diff) infections.

Sepsis Prevention Efforts

The findings line up with previous research, published in the JAMA Network Open journal, which indicated sepsis alert systems helped reduce the risk of serious infections by 20%.

Last year, the U.S. Centers for Disease Control and Prevention (CDC) found that more than 2 million Americans get sepsis every year and roughly 300,000 of those patients will die because the infection is hard to treat and can escalate quickly.

In August 2023, the CDC released new sepsis prevention guidelines designed to help hospitals and healthcare facilities reduce the risk of sepsis infections. The guidelines are designed to help hospitals implement, monitor and improve their sepsis programs, according to the agency. They call for early and rapid diagnosis of sepsis and immediate treatment.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Both Abbott Laboratories and Boston Scientific are fighting against a call by plaintiffs to consolidate all spinal cord stimulator lawsuits before one federal judge for pretrial proceedings.
More than 4,000 women across the U.S. have filed product liability lawsuits and medical monitoring class action claims seeking compensation for potential brain tumor symptoms and side effects allegedly caused by Depo-Provera.
Plaintiffs in Uber driver sexual assault lawsuits have asked a federal judge to approve a Common Benefit Funds motion, which is usually a sign of some form of settlement agreement.